Zevra Therapeutics, Inc. (ZVRA)

8.38 -0.11 (-1.30%) USD  |  NASDAQ  |  Jan 12, 16:00
8.29 -0.09 (-1.07%) After-Hours: 20:00
More

Zevra Therapeutics Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for ZVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

View Non-Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
XOMA Royalty Corp. Upgrade
Verastem, Inc. --
ADMA Biologics, Inc. Upgrade
Akebia Therapeutics, Inc. --
NovaBay Pharmaceuticals, Inc. --